| Literature DB >> 25788018 |
Feng J He1, Yangfeng Wu2, Xiang-Xian Feng3, Jun Ma4, Yuan Ma5, Haijun Wang4, Jing Zhang6, Jianhui Yuan3, Ching-Ping Lin7, Caryl Nowson8, Graham A MacGregor9.
Abstract
OBJECTIVE: To determine whether an education programme targeted at schoolchildren could lower salt intake in children and their families.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25788018 PMCID: PMC4364292 DOI: 10.1136/bmj.h770
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Fig 1 Trial profile of school based education programme to reduce salt intake in children and their families
Baseline characteristics of participants in study of school based education programme to reduce salt intake in children and their families*. Figures are numbers (percentage) unless stated otherwise
| Control (no salt education) | Intervention (salt education) | All | |
|---|---|---|---|
| Schools | 14 | 14 | 28 |
| Median (range) No of children/school | 10 (9-10) | 10 (10-11) | 10 (9-11) |
| Median (range) No of adults/school | 20 (17-20) | 20 (19-20) | 20 (17-20) |
| Median (range) No of adults/family | 2 (1-2) | 2 (1-2) | 2 (1-2) |
| Total participants | 413 | 419 | 832 |
| Children: | |||
| Total (No, % boys) | 138 (67, 48.6) | 141 (67, 47.5) | 279 (134, 48.0) |
| Mean (SD) age (year) | 10.2 (0.5) | 10.0 (0.5) | 10.1 (0.5) |
| Mean (SD) weight (kg) | 33.3 (7.2) | 33.4 (7.8) | 33.3 (7.5) |
| Mean (SD) height (cm) | 140.7 (6.6) | 139.2 (6.2) | 140.0 (6.5) |
| Mean (SD) BMI | 16.7 (2.7) | 17.1 (3.2) | 16.9 (3.0) |
| Adults: | |||
| Total (No, % men) | 275 (133, 48.4) | 278 (135, 48.6) | 553 (268, 48.5) |
| Parents | 208 (75.6) | 203 (73.0) | 411 (74.3) |
| Grandparents | 67 (24.4) | 75 (27.0) | 142 (25.7) |
| Mean (SD) age (year) | 43.6 (11.8) | 43.9 (12.5) | 43.8 (12.2) |
| Mean (SD) weight (kg) | 66.2 (12.9) | 66.1 (11.6) | 66.2 (12.3) |
| Mean (SD) Height (cm) | 162.8 (8.7) | 162.4 (8.0) | 162.6 (8.4) |
| Mean (SD) BMI | 24.9 (3.6) | 25.0 (3.4) | 24.9 (3.5) |
| Education: | |||
| ≤6 year | 55 (20.0) | 59 (21.2) | 114 (20.6) |
| 6-9 year | 132 (48.0) | 137 (49.3) | 269 (48.6) |
| >9 year | 88 (32.0) | 82 (29.5) | 170 (30.7) |
| Alcohol drinkers | 101 (36.7) | 84 (30.2) | 185 (33.5) |
| Smokers | 79 (28.7) | 76 (27.3) | 155 (28.0) |
| Self reported hypertension | 33 (12.0) | 42 (15.1) | 75 (13.6) |
| BP treatment in hypertensives | 28 (84.8) | 36 (85.7) | 64 (85.3) |
BMI=body mass index; BP=blood pressure.

Fig 2 Amount of salt used in intervention group according to weight of salt containers
Salt intake as calculated from 24 hour urinary sodium, other urinary measurements, and blood pressure based on intention to treat analysis in study of school based education programme to reduce salt intake in children and their families
| Control (no salt education) | Intervention (salt education) | Adjusted difference† (intervention | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline* (SE) | End of trial* (SE) | Change from baseline* (95% CI) | Baseline* (SE) | End of trial* (SE) | Change from baseline* (95% CI) | |||
| Urine volume (mL/24h) | 1337 (47) | 1475 (48) | 138 (89 to 188) | 1376 (47) | 1411 (47) | 35 (−14 to 83) | −99 (−169 to −30), 0.005 | |
| Urinary sodium (mmol/24h) | 167.6 (5.7) | 183.1 (5.7) | 15.5 (8.7 to 22.3) | 184.3 (5.7) | 155.9 (5.7) | −28.5 (−35.2 to −21.8) | −44.4 (−53.9 to −34.9), <0.001 | |
| Salt (g/d) | 9.8 (0.3) | 10.7 (0.3) | 0.9 (0.5 to 1.3) | 10.8 (0.3) | 9.1 (0.3) | −1.7 (−2.1 to −1.3) | −2.6 (−3.2 to −2.0), <0.001 | |
| Urinary potassium (mmol/24h) | 32.5 (0.9) | 33.9 (0.9) | 1.4 (−0.04 to 2.8) | 31.8 (0.9) | 33.7 (0.9) | 2.0 (0.6 to 3.3) | 0.6 (−1.4 to 2.5), 0.59 | |
| Urinary creatinine (mmol/24h) | 7.8 (0.2) | 7.8 (0.2) | 0.1 (−0.1 to 0.2) | 7.9 (0.2) | 7.8 (0.2) | −0.1 (−0.3 to 0.03) | −0.2 (−0.5 to 0.04), 0.10 | |
| Systolic BP (mm Hg) | 118.1 (1.2) | 122.9 (1.2) | 4.8 (3.6 to 6.0) | 120.1 (1.2) | 123.6 (1.2) | 3.5 (2.3 to 4.7) | −1.8 (−3.4 to −0.1), <0.04 | |
| Diastolic BP (mm Hg) | 75.5 (0.9) | 78.8 (1.0) | 3.3 (2.3 to 4.4) | 76.5 (0.9) | 79.1 (0.9) | 2.6 (1.6 to 3.6) | −1.1 (−2.5 to 0.4), 0.15 | |
| Urine volume (mL/24h) | 862 (38) | 952 (38) | 90 (35 to 145) | 867 (37) | 831 (38) | −37 (−91 to 18) | −124 (−201 to −46), 0.002 | |
| Urinary sodium (mmol/24h) | 116.7 (5.2) | 137.2 (5.2) | 20.5 (12.6 to 28.4) | 124.2 (5.1) | 112.2 (5.1) | −12.1 (−19.9 to −4.2) | −33.3 (−44.2 to −22.3), <0.001 | |
| Salt (g/d) | 6.8 (0.3) | 8.0 (0.3) | 1.2 (0.7 to 1.7) | 7.3 (0.3) | 6.6 (0.3) | −0.7 (−1.2 to −0.2) | −1.9 (−2.6 to −1.3), <0.001 | |
| Urinary potassium (mmol/24h) | 25.4 (0.9) | 25.9 (0.9) | 0.5 (−1.2 to 2.3) | 23.5 (0.9) | 25.3 (0.9) | 1.8 (0.1 to 3.5) | 1.3 (−1.1 to 3.8), 0.28 | |
| Urinary creatinine (mmol/24h) | 4.9 (0.2) | 5.2 (0.2) | 0.4 (0.2 to 0.5) | 4.7 (0.2) | 5.1 (0.2) | 0.4 (0.2 to 0.5) | −0.006 (−0.2 to 0.2), 0.96 | |
| Systolic BP (mm Hg) | 106.2 (1.0) | 110.6 (1.0) | 4.4 (2.8 to 6.0) | 106.2 (1.0) | 110.0 (1.0) | 3.8 (2.3 to 5.4) | −0.8 (−3.0 to 1.5), 0.51 | |
| Diastolic BP (mm Hg) | 66.8 (1.1) | 70.2 (1.1) | 3.4 (1.6 to 5.1) | 67.0 (1.1) | 69.4 (1.1) | 2.4 (0.7 to 4.1) | −1.2 (−3.7 to 1.2), 0.33 | |
| Urine volume (mL/24h) | 1577 (61) | 1740 (62) | 163 (94 to 232) | 1636 (61) | 1709 (61) | 73 (5 to 141) | −86 (−183 to 10), 0.08 | |
| Urinary sodium (mmol/24h) | 193.4 (6.7) | 206.6 (6.8) | 13.2 (3.8 to 22.6) | 215.1 (6.7) | 178.5 (6.7) | −36.6 (−45.8 to −27.3) | −50.0 (−63.1 to −36.8), <0.001 | |
| Salt (g/d) | 11.3 (0.4) | 12.1 (0.4) | 0.8 (0.2 to 1.3) | 12.6 (0.4) | 10.4 (0.4) | −2.1 (−2.7 to −1.6) | −2.9 (−3.7 to −2.2), <0.001 | |
| Urinary potassium (mmol/24h) | 36.1 (1.0) | 38.0 (1.0) | 1.9 (−0.1 to 3.8) | 36.0 (1.0) | 38.1 (1.0) | 2.1 (0.2 to 4.0) | 0.1 (−2.6 to 2.9), 0.93 | |
| Urinary creatinine (mmol/24h) | 9.3 (0.2) | 9.2 (0.2) | −0.1 (−0.4 to 0.1) | 9.5 (0.2) | 9.1 (0.2) | −0.4 (−0.7 to −0.2) | −0.3 (−0.6 to 0.04), 0.09 | |
| Systolic BP (mm Hg) | 124.1 (1.5) | 129.1 (1.5) | 5.0 (3.4 to 6.6) | 127.1 (1.5) | 130.5 (1.5) | 3.4 (1.8 to 4.9) | −2.3 (−4.5 to −0.04), <0.05 | |
| Diastolic BP (mm Hg) | 79.9 (1.0) | 83.2 (1.1) | 3.3 (2.0 to 4.6) | 81.4 (1.0) | 84.1 (1.0) | 2.8 (1.5 to 4.0) | −0.9 (−2.8 to 0.9), 0.31 | |
BP=blood pressure.
*Adjusted for stratification variables at randomisation (school location and class size).
†Adjusted for age, sex, BMI, stratification variables at randomisation (school location and class size), and indoor and outdoor temperature.
Sensitivity analysis for salt intake (g/day) as calculated from 24 hour urinary sodium
| No in control/intervention | Control | Intervention | Adjusted difference† (intervention | ||||
|---|---|---|---|---|---|---|---|
| Baseline* (SE) | Change from baseline* (95% CI) | Baseline* (SE) | Change from baseline* (95% CI) | ||||
| Population excluding possible incomplete 24h urine: | |||||||
| All | 411/415 | 10.0 (0.3) | 0.9 (0.6 to 1.3) | 11.0 (0.3) | −1.6 (−2.0 to −1.2) | −2.6 (−3.1 to −2.1), <0.001 | |
| Children | 138/140 | 7.0 (0.3) | 1.2 (0.7 to 1.6) | 7.5 (0.3) | −0.7 (−1.1 to −0.2) | −1.9 (−2.6 to −1.2), <0.001 | |
| Adults | 273/275 | 11.6 (0.4) | 0.8 (0.3 to 1.4) | 12.8 (0.4) | −2.1 (−2.6 to −1.6) | −3.0 (−3.7 to −2.2), <0.001 | |
| Completers‡: | |||||||
| All | 396/410 | 9.8 (0.3) | 0.9 (0.5 to 1.3) | 10.8 (0.3) | −1.7 (−2.1 to −1.3) | −2.6 (−3.2 to −2.1), <0.001 | |
| Children | 135/139 | 6.8 (0.3) | 1.2 (0.8 to 1.7) | 7.2 (0.3) | −0.7 (−1.2 to −0.2) | −1.9 (−2.6 to −1.3), <0.001 | |
| Adults | 261/271 | 11.4 (0.4) | 0.8 (0.2 to 1.3) | 12.7 (0.4) | −2.2 (−2.7 to −1.6) | −3.0 (−3.7 to −2.2), <0.001 | |
| Per protocol population§: | |||||||
| All | 381/393 | 10.0 (0.3) | 1.0 (0.6 to 1.4) | 11.0 (0.3) | −1.6 (−2.0 to −1.2) | −2.6 (−3.2 to −2.1), <0.001 | |
| Children | 132/137 | 7.0 (0.3) | 1.2 (0.7 to 1.7) | 7.5 (0.3) | −0.7 (−1.1 to −0.2) | −1.9 (−2.6 to −1.3), <0.001 | |
| Adults | 249/256 | 11.6 (0.4) | 0.9 (0.3 to 1.4) | 12.9 (0.4) | −2.1 (−2.6 to −1.6) | −3.0 (−3.7 to −2.3), <0.001 | |
*Adjusted for stratification variables at randomisation (school location and class size).
†Adjusted for age, sex, body mass index, stratification variables at randomisation (school location and class size), and indoor and outdoor temperature.
‡Participants with 24 hour urine collections at baseline and end of trial.
§Completers with complete 24 hour urine collections.